Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Carbapenem-resistant Organisms (CRO) Screening From Rectal Swabs and the Relationship Between Colonization and Infection in Patients With Hematological Diseases in China

NCT05002582 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.

NCT NCT05002582
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05002582 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Carbapenem-resistant Organisms (CRO) Screening From Rectal Swabs and the Relationship Between Colonization and Infection in Patients With Hematological Diseases in China
Lead sponsor
Sir Run Run Shaw Hospital
Phase
Observational
Overall status
Unknown status
Start date
January 1, 2021
Completion date
December 31, 2022
Enrollment
5,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

carbapenem-resistant acinetobacter baumannii, carbapenem-resistant enterobacteriaceae, carbapenem-resistant pseudomonas aeruginosa, hematological diseases